首页> 美国政府科技报告 >Combined Therapy of Septicemia with Ofloxacin and/or Synthetic Trehalose Dicorynomycolate (S-TDCM) in Irradiated and Wounded Mice (Kombinierte Therapie der Septikaemie mit Ofloxacin und/oder Synthetischem Trehalose-Dicorynomycolat (S-TDCM) bei Bestrahlten
【24h】

Combined Therapy of Septicemia with Ofloxacin and/or Synthetic Trehalose Dicorynomycolate (S-TDCM) in Irradiated and Wounded Mice (Kombinierte Therapie der Septikaemie mit Ofloxacin und/oder Synthetischem Trehalose-Dicorynomycolat (S-TDCM) bei Bestrahlten

机译:败血症与氧氟沙星和/或合成海藻糖二十二烷酸酯(s-TDCm)联合治疗辐照和受伤小鼠(Kombinierte Therapie der septikaemie mit Ofloxacin und / oder synthetischem Trehalose-Dicorynomycolat(s-TDCm)bei Bestrahlten

获取原文

摘要

Following lethal irradiation, mice usually succumb to sepsis as a result of translocation of intestinal bacteria and impairment of the host defense system. Additional trauma in these immunocompromised mice further increases susceptibility to bacterial infection from either endogenous or exogenous origin. Treatment with ofloxacin or synthetic trehalose dicorynemycolate (S-TDCM) was evaluated in mice, which were lethally irradiated and wounded, and which died with sepsis within six days. Wounding was performed on C3H/HeN mice anesthetized by inhalation of methoxyfurane. Dorsal skin and muscle equal to 30% total body surface was removed 1 h after 8.0 Gy gamma radiation. S-TDCM, which augments nonspecific resistance to infection in irradiated mice, was given once i.p. immediately after wounding. Oxfloxacin was injected s.c. daily from day 0 to day 10. Staphylococcus aureus, Streptococcus faecium, and Escherichia coli were isolated from both the livers and wound sites of moribund, untreated mice 4 and 5 days postirradiation.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号